Lynne Braidwood

Virttu Biologics (United Kingdom) — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

7h-index317citations16works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(12), Herpesvirus Infections and Treatments(6), Cancer Research and Treatments(5), Viral Infectious Diseases and Gene Expression in Insects(4), CAR-T cell therapy research(3)

Publications16 total

Please Stand By: How Oncolytic Viruses Impact Bystander Cells
Future Virology·2018· 6 cited
High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy
Viruses·2018· 13 citedOpen Access
Oncolytic HSV1716 in combination with targeted anti cancer agents : identification of synergistic interactions and their mechanisms of synergy
2016· 1 cited
Abstract B033: Cytokine responses following intrapleural administration of oncolytic HSV SEPREHVIR® in patients with malignant pleural mesothelioma
Cancer Immunology Research·2016· 1 cited
Immune responses following intrapleural administration of oncolytic SEPREHVIR in patients with malignant pleural mesothelioma
Journal for ImmunoTherapy of Cancer·2015· 4 citedOpen Access
Investigating the efficacy of a new diuretic in dogs with pulmonary oedema
Veterinary Record·2014
8th International Conference on Oncolytic Virus Therapeutics
Human Gene Therapy·2014· 3 cited
Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models
Journal of Hepatocellular Carcinoma·2014· 10 citedOpen Access
Autophagy in human cancer cell lines during infection with the ICP34.5-deleted oncolytic HSV1716
Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)·2014
Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs
Oncolytic Virotherapy·2013· 7 citedOpen Access
Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy
Cancer Gene Therapy·2012· 19 citedOpen Access
In Vivo Evaluation of a Cancer Therapy Strategy Combining HSV1716-Mediated Oncolysis with Gene Transfer and Targeted Radiotherapy
Journal of Nuclear Medicine·2012· 19 citedOpen Access
Efficacy in vivo of a cancer therapy strategy combining HSV1716 mediated oncolysis with gene transfer and targeted radiotherapy
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)·2012
Antitumor activity of a selectively replication competent herpes simplex virus (HSV) with enzyme prodrug therapy.
PubMed·2009· 20 cited
A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein
Gene Therapy·2008· 43 citedOpen Access
Bidirectional tachycardia in a child. A study using His bundle electrography.
Heart·1975· 171 citedOpen Access

Frequent Co-authors

Joe Conner(11), Kirsty Learmonth(4), Stuart M. Brown(3), Annette Sørensen(2), Robert J. Mairs(2), Craig Joyce(2), Sally L. Pimlott(2), Marie Boyd(2), Leslee Sprague(2), Kevin A. Cassady(2), Timothy P. Cripe(2), Alex Graham(2), Penella J. Woll(2), D S Reid(1), Michael Tynan(1), G. R. Fitzgerald(1), Paul Dunn(1), Susan Hardy(1), T.R. Jeffry Evans(1), M. Brown(1)